PASW Ping An Biomedical Co., Ltd. Annual reports only
Apparel & Other Finishd Prods of Fabrics & Similar Matl · Nasdaq · SEC CIK 1897532 · Reporting currency CNY
Financial factors as of 2025-09-30 (FY2025), by fiscal year; growth vs the previous fiscal year
Growth
TTM revenue YoY-61.0%
TTM net income YoY-899.0%
TTM EPS YoY-885.7%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin2.8%
Operating margin-43.1%
Net margin-37.6%
FCF margin—
EBITDA margin-43.0%
Returns
ROE-67.4%
ROA-20.5%
ROIC (approx.)-63.2%
Asset turnover0.55x
Leverage & solvency
Liabilities / assets33.9%
Debt / equity0.00x
Current ratio2.76x
Interest coverage-47.88x
Cash quality & payout
Operating cash flow / net income0.50x
Accruals ratio-10.2%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Unit: CNY | FY20252025-09-30 | FY20242024-09-30 | FY20232023-09-30 |
|---|---|---|---|
| Income statement | |||
| Revenue | 34.15M | 87.62M | 82.56M |
| Cost of revenue | 33.20M | 82.21M | 78.32M |
| Gross profit | 949,505 | 5.42M | 4.24M |
| SG&A expense | 6.01M | 4.99M | 3.27M |
| Operating income | -14.70M | -2,039 | 612,481 |
| Interest expense | 307,055 | 705,273 | 1.74M |
| Pretax income | -14.68M | -682,716 | 41,686 |
| Income tax | 1.86M | -601,456 | -1.04M |
| Net income | -12.83M | -1.28M | -993,937 |
| EBITDA | -14.70M | 8,200 | 645,237 |
| EPS (basic) | -0.69 | -0.07 | -0.06 |
| EPS (diluted) | -0.69 | -0.07 | -0.06 |
| Weighted avg. shares (diluted) | 18.48M | 18.00M | 18.00M |
| Balance sheet | |||
| Cash & equivalents | 1.17M | 130,923 | 591,874 |
| Receivables | 16.93M | 40.44M | — |
| Inventory | 441,904 | 127,296 | — |
| Current assets | 63.70M | 53.31M | — |
| PP&E, net | — | 5,585 | — |
| Total assets | 68.41M | 56.85M | — |
| Current liabilities | 23.08M | 63.58M | — |
| Short-term debt | 10.00M | 10.00M | — |
| Total liabilities | 23.17M | 64.04M | — |
| Shareholders' equity | 45.24M | -7.19M | -5.86M |
| Shares outstanding | 20.50M | 18.00M | — |
| Cash flow statement | |||
| Operating cash flow | -6.43M | 14.63M | -6.08M |
| Investing cash flow | 0 | 15.00M | -3.37M |
| Financing cash flow | 43.66M | -30.09M | 8.87M |
| Depreciation & amortization | 5,585 | 10,239 | 32,756 |
| Dividends paid | — | 322,412 | 9.60M |
· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.
· Amounts are in the company's reporting currency, CNY, not USD; the site does no currency conversion.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.